Integrative bioinformatics and preliminary experimental validation suggest the therapeutic potential of lycorine in uterine corpus endometrial carcinoma
5 affiliations
- 1Department of Clinical Laboratory, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
- 2Department of Clinical College, Hebei Medical University, Shijiazhuang, China
- 3Department of Information and Communication, Branch of State Grid Hebei Electric Power Co., Ltd, Shijiazhuang, China
- 4College of Medical Technology, Hebei Medical University, Shijiazhuang, China
- 5Department of Gynecology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
Abstract
Uterine corpus endometrial carcinoma (UCEC) is one of the most prevalent gynecological malignancies worldwide and remains a significant threat to women’s health. Lycorine, a natural alkaloid isolated from plants of the Amaryllidaceae family, has attracted considerable attention owing to its diverse pharmacological activities, particularly its anti-tumor properties. However, the potential therapeutic targets and action mechanism of lycorine in UCEC remain unclear.
In this study, an integrated strategy combining bioinformatic analysis and preliminary experimental validation was used to elucidate the anti-tumor mechanisms of lycorine in UCEC. Potential targets of lycorine were predicted using public databases and intersected with differentially expressed genes derived from The Cancer Genome Atlas (TCGA) UCEC dataset. Subsequently, a protein–protein interaction (PPI) network was constructed, and Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were used to investigate the biological functions and pathways associated with these targets. Prognostic analysis and Cox regression were used to establish a risk prediction model. Immune infiltration analysis was performed to evaluate the relationship between key genes and the tumor immune microenvironment.
Results revealed 10 potential targets of lycorine associated with UCEC. Functional enrichment analysis indicated that these genes were mainly involved in cholinergic synapse and neuroactive ligand–receptor interaction pathways. Three key genes (ACHE, MAN2B1, and PNP) were further identified to construct a prognostic model, which showed moderate predictive performance in survival analysis. Immune infiltration analysis revealed that these genes were associated with multiple immune cell populations in the tumor microenvironment. Molecular docking revealed that the binding energies of ACHE, MAN2B1, and PNP with lycorine were ≤ − 7.0 kcal/mol, indicating stable binding. In vitro experiments confirmed that lycorine significantly inhibited the proliferation of Ishikawa endometrial cancer cells.
In conclusion, this study provides new insights into the potential therapeutic effects of lycorine in UCEC and identifies ACHE, MAN2B1, and PNP as promising therapeutic targets for further investigation.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12906-026-05666-y.
Related
- Per- and Polyfluoroalkyl Substances and Papillary Thyroid Carcinoma: An Integrative Study of Bioinformatics, Epidemiological Associations, and In Vitro Responses
- Bioinformatics-guided discovery and functional verification of fungal polyester hydrolases for polycaprolactone degradation
- Leveraging bioinformatics approaches for drug repositioning in space radiation protection
- Exploring the Underlying Molecular Mechanisms of Chaetomugilin Q in Breast Cancer Using Network Pharmacology, Molecular Docking, and Bioinformatics
- Physicochemical and Structural Determinants of BACE1-Selective Inhibition: An Integrative Modeling Study using A Combined Ligand-and Structure-Based Approach
BibTeX
@article{dong2026integrative,
title = {{Integrative bioinformatics and preliminary experimental validation suggest the therapeutic potential of lycorine in uterine corpus endometrial carcinoma}},
author = {Pei Dong and Lejun Xia and Lincong Zhao and Yuyue Liu and Zixuan Gao and Xu Han and Zixuan Su and Ming Ma and Yanan Zhang},
journal = {BMC Complementary Medicine and Therapies},
year = {2026},
month = nov,
doi = {10.1186/s12906-026-05666-y},
url = {https://doi.org/10.1186/s12906-026-05666-y},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Integrative bioinformatics and preliminary experimental validation suggest the therapeutic potential of lycorine in uterine corpus endometrial carcinoma
AU - Pei Dong
AU - Lejun Xia
AU - Lincong Zhao
AU - Yuyue Liu
AU - Zixuan Gao
AU - Xu Han
AU - Zixuan Su
AU - Ming Ma
AU - Yanan Zhang
PY - 2026
DA - 2026/11/04
JO - BMC Complementary Medicine and Therapies
DO - 10.1186/s12906-026-05666-y
UR - https://doi.org/10.1186/s12906-026-05666-y
AB - Uterine corpus endometrial carcinoma (UCEC) is one of the most prevalent gynecological malignancies worldwide and remains a significant threat to women’s health. Lycorine, a natural alkaloid isolated from plants of the Amaryllidaceae family, has attracted considerable attention owing to its diverse pharmacological activities, particularly its anti-tumor properties. However, the potential therapeutic targets and action mechanism of lycorine in UCEC remain unclear. In this study, an integrated strategy combining bioinformatic analysis and preliminary experimental validation was used to elucidate the anti-tumor mechanisms of lycorine in UCEC. Potential targets of lycorine were predicted using public databases and intersected with differentially expressed genes derived from The Cancer Genome Atlas (TCGA) UCEC dataset. Subsequently, a protein–protein interaction (PPI) network was constructed, and Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were used to investigate the biological functions and pathways associated with these targets. Prognostic analysis and Cox regression were used to establish a risk prediction model. Immune infiltration analysis was performed to evaluate the relationship between key genes and the tumor immune microenvironment. Results revealed 10 potential targets of lycorine associated with UCEC. Functional enrichment analysis indicated that these genes were mainly involved in cholinergic synapse and neuroactive ligand–receptor interaction pathways. Three key genes (ACHE, MAN2B1, and PNP) were further identified to construct a prognostic model, which showed moderate predictive performance in survival analysis. Immune infiltration analysis revealed that these genes were associated with multiple immune cell populations in the tumor microenvironment. Molecular docking revealed that the binding energies of ACHE, MAN2B1, and PNP with lycorine were ≤ − 7.0 kcal/mol, indicating stable binding. In vitro experiments confirmed that lycorine significantly inhibited the proliferation of Ishikawa endometrial cancer cells. In conclusion, this study provides new insights into the potential therapeutic effects of lycorine in UCEC and identifies ACHE, MAN2B1, and PNP as promising therapeutic targets for further investigation. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12906-026-05666-y.
SN - 2662-7671
ER -